Overview
Antimony pneumoconiosis is a respiratory condition resulting from inhalation of antimony dust, leading to pulmonary inflammation and potential severe complications including multiple organ failure 1.Diagnosis
Clinical history of exposure to antimony dust
Radiographic findings: pulmonary infiltrates, nodules, or interstitial changes 1
Laboratory tests: elevated inflammatory markers (e.g., CRP, ESR) 1
Toxicological analysis of biological samples (blood, urine, tissues) for antimony levels 1Management
Supportive care: mechanical ventilation if respiratory failure occurs 1
Chelation therapy: deferoxamine or dimercaprol may be considered for severe cases (specific dosing not provided in abstracts) 1
Corticosteroids: to reduce inflammation (dosing not specified) 1Special Populations
Elderly: Higher risk of severe outcomes; one fatal case reported in a 93-year-old patient 1
No specific data provided for pregnancy or pediatric populations 1Key Recommendations
Conduct thorough toxicological analysis including blood, urine, and tissue samples for antimony levels to confirm diagnosis (Evidence: Weak) 1
Initiate supportive care measures, including mechanical ventilation if respiratory failure develops (Evidence: Weak) 1
Consider chelation therapy for severe cases, though specific dosing recommendations are not provided (Evidence: Weak) 1References
1 Lauwers LF, Roelants A, Rosseel PM, Heyndrickx B, Baute L. Oral antimony intoxications in man. Critical care medicine 1990. link